
Altimmune to put its incretin into addiction trials; Tarsus aims to raise $125M
Plus, news about Heidelberg, Accropeutics, Allarity Therapeutics, Cadrenal and Inovio:
Altimmune to test its incretin in addiction: Following the path set by Novo Nordisk …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.